Insights

Global Market Presence Intas Pharmaceuticals operates in over 85 countries and has established a robust network of subsidiaries including Accord Healthcare in key markets such as the EU, US, Canada, and Australia, making it a strategic partner for expanding distribution channels and penetrating new markets.

Diverse Biosimilar Portfolio With a strategic pipeline of over 300 biosimilars and high-value formulations including approved products like Udenyca and Hetronifly, Intas presents significant opportunities for sales teams to promote established and new biosimilar therapies across both developed and emerging markets.

Strong Regulatory Backing The company’s facilities are accredited by multiple global regulators such as USFDA, EMA, and MHRA, enabling easier access and faster approval processes for new products, thus opening avenues for sales of innovative formulations in highly regulated environments.

Innovation in Oncology Intas’s recent launch of Hetronifly, the first PD-1 inhibitor approved for ES-SCLC, showcases its focus on innovative oncology therapies, offering opportunities to engage healthcare providers with cutting-edge treatments for cancer patients.

Recent Strategic Acquisitions The acquisition of biosimilar drug assets from Coherus BioSciences and exclusive development rights for high-sale biosimilars like nivolumab indicate potential for expanding market share and tailored sales strategies in highly lucrative biosimilar segments globally.

Similar companies to Intas Biopharmaceuticals Ltd.

Intas Biopharmaceuticals Ltd. Tech Stack

Intas Biopharmaceuticals Ltd. uses 8 technology products and services including SAP FICO, Adobe, Backbone.js, and more. Explore Intas Biopharmaceuticals Ltd.'s tech stack below.

  • SAP FICO
    Accounting
  • Adobe
    Audio, Video, Graphics
  • Backbone.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • SAP ABAP
    Programming Languages
  • Google
    Search Engines
  • X-XSS-Protection
    Security
  • Adobe Creative Suite
    Visualisation Software

Media & News

Intas Biopharmaceuticals Ltd.'s Email Address Formats

Intas Biopharmaceuticals Ltd. uses at least 1 format(s):
Intas Biopharmaceuticals Ltd. Email FormatsExamplePercentage
First_Last@intaspharma.comJohn_Doe@intaspharma.com
94%
FirstLast@intaspharma.comJohnDoe@intaspharma.com
3%
FLast@intaspharma.comJDoe@intaspharma.com
2%
F_Last@intaspharma.comJ_Doe@intaspharma.com
1%

Frequently Asked Questions

What is Intas Biopharmaceuticals Ltd.'s phone number?

Minus sign iconPlus sign icon
You can contact Intas Biopharmaceuticals Ltd.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Intas Biopharmaceuticals Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd.'s official website is intaspharma.com and has social profiles on LinkedInCrunchbase.

How much revenue does Intas Biopharmaceuticals Ltd. generate?

Minus sign iconPlus sign icon
As of December 2025, Intas Biopharmaceuticals Ltd.'s annual revenue is estimated to be $5B.

What is Intas Biopharmaceuticals Ltd.'s NAICS code?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Intas Biopharmaceuticals Ltd. have currently?

Minus sign iconPlus sign icon
As of December 2025, Intas Biopharmaceuticals Ltd. has approximately 19K employees across 6 continents, including AsiaSouth AmericaNorth America. Key team members include Chief Executive Officer: R. J. M.Chief Executive Officer: V. B.Cfo: J. S.. Explore Intas Biopharmaceuticals Ltd.'s employee directory with LeadIQ.

What industry does Intas Biopharmaceuticals Ltd. belong to?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd. operates in the Pharmaceutical Manufacturing industry.

What technology does Intas Biopharmaceuticals Ltd. use?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd.'s tech stack includes SAP FICOAdobeBackbone.jsjQuerySAP ABAPGoogleX-XSS-ProtectionAdobe Creative Suite.

What is Intas Biopharmaceuticals Ltd.'s email format?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd.'s email format typically follows the pattern of First_Last@intaspharma.com. Find more Intas Biopharmaceuticals Ltd. email formats with LeadIQ.

When was Intas Biopharmaceuticals Ltd. founded?

Minus sign iconPlus sign icon
Intas Biopharmaceuticals Ltd. was founded in 1976.

Intas Biopharmaceuticals Ltd.

Pharmaceutical ManufacturingGujarat, India10001+ Employees

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.

Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.

Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products.
 
Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.

The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.

Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1976
Employees
10001+

Section iconFunding & Financials

  • $1B$10B

    Intas Biopharmaceuticals Ltd.'s revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Intas Biopharmaceuticals Ltd.'s revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.